secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuronetics, Inc. (STIM)
CIK:        0001227636
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001558370-23-017856
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuronetics Q3 revenue $17.9M (+8% YoY); net loss $(9.4)M; narrows FY 2023 guidance
--------------------------------------------------------------------------------

- Revenue $17.9M (+8% YoY); record US treatment session revenue $13.1M (+10% YoY).
- Gross margin 65.8% (down from 78.4%) due to $1.9M inventory write-off; adjusted 77.3%.
- Net loss $(9.4)M or $(0.33)/share vs $(7.6)M or $(0.28)/share last year.
- Drew down remaining $22.5M from SLR credit facility; cash $35.8M vs $70.3M at Dec 31, 2022.
- FY 2023 revenue guidance narrowed to $70-72M; Q4 revenue expected $19-21M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1227636/000155837023017856/0001558370-23-017856-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1227636/000155837023017856/stim-20231107x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-017856

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer